We are thrilled to return for another episode of the Life Sciences Today Podcast, brought to you by Healthcare IT Today. Today, I am joined by Dr. Nicole Yurgin, who is a Market Access Consultant at Yurgin Advisory.
In this installment, I converse with Yurgin, an individual possessing a distinct set of experiences and perspectives regarding market access in the United States and Europe. Following the completion of her economics doctoral degree and a stint in academia, she joined the ranks of Eli Lilly, specifically within the realm of market access and health economics.
Subsequently, she spent two decades working within the confines of large pharmaceutical corporations throughout the US. Yurgin was subsequently invited to join the ranks of Novartis Basel during the recent pandemic. Despite the challenges of relocating with a newborn and her husband during these trying times, she successfully transitioned from her home in Los Angeles to her current base in Basel.
This city serves as the epicenter for over 800 life science companies and 30,000 healthcare professionals. She departed from Novartis to establish her own consultancy, choosing to remain in Basel due to the high quality of life and presence of numerous industries. For this episode of the Life Sciences Today podcast, the main subjects of conversation are:.
Please share your background, experiences, and current position as a consultant. How do you add value to your clients’ businesses? What special ability do you possess?
I have received information from numerous medical device companies suggesting that European companies generally prioritize scientific and technical precision, and may struggle more with managing their capacity to navigate the American payment system. Have you encountered the same situation?
